Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE 100 treads water at eight-month high

Tue, 21st Jan 2014 16:38

- FTSE 100 fails to break 2013 intraday high- Credit squeeze eases in China- IMF lifts global growth forecaststechMARK 2,846.40 -0.25%FTSE 100 6,834.26 -0.04%FTSE 250 16,144.20 -0.51%After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not reached in eight months.An easing of credit conditions in China and upwards revisions to growth estimates by the International Monetary Fund (IMF) failed to keep the Footsie in positive territory today, as cautiousness set in after a 3.5% rise over the past month.Despite US markets reopening after a three-day weekend - Wall Street was closed for Martin Luther King Jr. Day yesterday - it was another lacklustre session in London with trading rangebound for most of the day. The benchmark FTSE 100 finished at 6,834.26, down just 2.47 points, erasing gains late on after coming close to last year's intraday high of 6,875 in afternoon trade. Yesterday, the index hit 6,836.72, its best closing level since reaching 6,840.27 in May 2013.Toby Morris, Senior Sales Trader at CMC Markets, said that the 6,875 intraday high reached last year is "the only historical resistance to break before taking on all-time high recorded back in 1999".Stocks rose initially this morning, tracking gains for Asian markets overnight on the back of an easing of credit conditions in China as the central bank injected fresh liquidity into the country's large banks to meet demand for cash ahead of Chinese New Year later this month.Meanwhile, the IMF lifted its growth forecast for the global economy to 3.7% for 2014, up from its previous estimate of 3.6%, owing to upwards revisions to forecasts in the UK, US, Europe and Japan.On a negative note, there was a surprise fall in the German ZEW index on economic sentiment which fell from 62 to 61.7 in January, worse than rise to 64 expected by analysts. The current situation index, however, jumped from 32.4 to 41.2.Intertek jumps on SGS readacross, Unilever gainsIntertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong growth in the emerging markets.Drugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. Mining stocks sank on weak metal prices, pushing Randgold Resources, Anglo American, Rio Tinto, Fresnillo, BHP Billiton, and Glencore Xstrata all firmly lower. Investors were also focusing on comments from Goldman Sachs, which adjusted its commodity price forecasts for 2014 and beyond. William Hill and Ladbrokes slumped after JPMorgan Cazenove expressed concerns about potential regulatory restrictions on machine gaming, which could result in "material downgrades and significant shop closures" at the bookmakers. Weir Group slumped after fellow oil services provider Baker Hughes highlighted higher costs for the sector in its fourth-quarter results. Baker said a surplus of natural-gas supply led to lower prices and pushed energy companies to shift operations to oil-rich shale, which is more difficult to tap. British Land was named as HSBC's key 'overweight'-rated company, giving the stock a lift today, as the bank gave an upbeat outlook for UK property sector.FTSE 100 - RisersAssociated British Foods (ABF) 2,806.00p +4.23%Intertek Group (ITRK) 3,000.00p +3.16%Hargreaves Lansdown (HL.) 1,549.00p +2.65%Imperial Tobacco Group (IMT) 2,284.00p +2.51%Standard Chartered (STAN) 1,358.00p +2.26%easyJet (EZJ) 1,710.00p +2.21%Coca-Cola HBC AG (CDI) (CCH) 1,768.00p +2.20%Diageo (DGE) 1,985.00p +1.95%Unilever (ULVR) 2,480.00p +1.76%Babcock International Group (BAB) 1,426.00p +1.71%FTSE 100 - FallersRio Tinto (RIO) 3,231.50p -3.13%Antofagasta (ANTO) 819.50p -3.02%Anglo American (AAL) 1,356.00p -2.66%Weir Group (WEIR) 2,174.00p -2.38%Aberdeen Asset Management (ADN) 426.00p -2.16%Morrison (Wm) Supermarkets (MRW) 250.10p -1.88%William Hill (WMH) 355.40p -1.82%Randgold Resources Ltd. (RRS) 4,112.00p -1.74%BHP Billiton (BLT) 1,854.50p -1.70%BAE Systems (BA.) 437.50p -1.49%FTSE 250 - RisersRank Group (RNK) 150.00p +3.88%African Barrick Gold (ABG) 206.50p +2.94%Homeserve (HSV) 304.30p +2.15%Petra Diamonds Ltd.(DI) (PDL) 125.00p +2.04%Ocado Group (OCDO) 527.00p +2.03%Xaar (XAR) 1,031.00p +1.98%Greencore Group (GNC) 242.70p +1.85%Grainger (GRI) 221.70p +1.70%JD Sports Fashion (JD.) 1,651.00p +1.60%Daejan Holdings (DJAN) 4,845.00p +1.57%FTSE 250 - FallersKazakhmys (KAZ) 185.50p -4.87%Ladbrokes (LAD) 158.60p -4.86%Ferrexpo (FXPO) 171.40p -4.78%Imagination Technologies Group (IMG) 199.80p -4.36%Kenmare Resources (KMR) 18.21p -3.65%Bodycote (BOY) 685.00p -3.52%Thomas Cook Group (TCG) 180.10p -3.28%Vedanta Resources (VED) 908.50p -3.04%Laird (LRD) 306.60p -2.97%Ophir Energy (OPHR) 299.40p -2.95%BC
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.